SLNSW-Low-dose hydroxycarbamide therapy may offer simil...-TN_cdi_proquest_journals_2114633152

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

Full title: Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

Author/creator: Inusa, Baba Psalm Duniya, Atoyebi, Wale, Hassan, Abdul Aziz, Idhate, Tushar, Dogara, Livingstone, Ijei, Ifeoma, Qin, Yewen, Anie, Kofi, Lawson, Juliana Olufunke, Hsu, Lewis.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2114633152

Language: English

Formats: Articles

Publishers: England: Faculty of 1000 Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2114633152

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

    Record identifier

    TN_cdi_proquest_journals_2114633152

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2114633152

    Share

    Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2114633152

    Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

    Full title

    Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings [version 1; peer review: 2 approved]

    Author / Creator

    Inusa, Baba Psalm Duniya ; Atoyebi, Wale ; Hassan, Abdul Aziz ; Idhate, Tushar ; Dogara, Livingstone ; Ijei, Ifeoma ; Qin, Yewen ; Anie, Kofi ; Lawson, Juliana Olufunke ; Hsu, Lewis

    Publisher

    England: Faculty of 1000 Ltd

    Journal title

    F1000 research, 2018, Vol.7, p.1407

    Record Identifier

    TN_cdi_proquest_journals_2114633152

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    anaemia Anemia Babies Blood transfusions Children Clinical trials Collaboration Developing countries Drug dosages Gangrene Hematology Hemoglobin hydroxycarbamide Hydroxyurea LDCs Literature reviews low-middle income countries Mortality Pain Patients Quality of life Review Sickle cell disease Young adults

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2114633152

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2114633152

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections